Skip to main content

Table 1 Association between MS and clinicopathologic characteristics of patients with TSCC

From: Metabolic syndrome is associated with better prognosis in patients with tongue squamous cell carcinoma

Characteristic

Number of patients (%)

P value

Total

With MS

Without MS

Age (years)

Ā Ā Ā 

0.426

ā€ƒā‰„52

134 (53)

28 (58)

106 (52)

Ā 

ā€ƒ<52

118 (47)

20 (42)

98 (48)

Ā 

Sex

Ā Ā Ā 

0.273

ā€ƒMale

145 (58)

31 (65)

114 (56)

Ā 

ā€ƒFemale

107 (42)

17 (35)

90 (44)

Ā 

T category

Ā Ā Ā 

0.524

ā€ƒT1/T2

222 (88)

41 (85)

181 (89)

Ā 

ā€ƒT3/T4

30 (12)

7 (15)

23 (11)

Ā 

N category

Ā Ā Ā 

<0.001

ā€ƒN0

130 (52)

36 (75)

94 (46)

Ā 

ā€ƒN+

122 (48)

12 (25)

110 (54)

Ā 

Pathologic grade

Ā Ā Ā 

0.598

ā€ƒWell differentiated

184 (73)

33 (69)

151 (74)

Ā 

ā€ƒModerately differentiated

58 (23)

12 (25)

46 (23)

Ā 

ā€ƒPoorly differentiated

10 (4)

3 (6)

7 (3)

Ā 

Treatment

Ā Ā Ā 

0.639

ā€ƒSurgery alone

193 (77)

38 (79)

155 (76)

Ā 

ā€ƒMultimodality therapy

59 (23)

10 (21)

49 (24)

Ā 

Tumor location

Ā Ā Ā 

0.653

ā€ƒLateral margin of the tongue

185 (73)

34 (71)

151 (74)

Ā 

ā€ƒOther locationsa

67 (27)

14 (29)

53 (26)

Ā 

Total

252

48

204

Ā 
  1. MS, metabolic syndrome; TSCC, tongue squamous cell carcinoma. aOther locations here include the apex linguae, dorsum, and ventrum of the tongue.